ArticleOncology letters2021

Generation of TIM3 inhibitory single-domain antibodies to boost the antitumor activity of chimeric antigen receptor T cells.

Liu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.